Multi-gene panel testing
A comprehensive 98-gene germline panel covers inherited predisposition across 23 cancer types, including BRCA1/2, Lynch syndrome genes, PALB2, ATM, CHEK2, and others.
Clinical Area · Hereditary Cancer
Hereditary cancer testing identifies germline variants that increase the risk of developing cancer. Results carry implications not just for the patient but for biological relatives — making appropriate ordering, consent, and post-result support essential.
All hereditary cancer testing through AC is ordered and interpreted through a qualified physician. Positive findings are discussed with the ordering clinician before cascade testing or surgical decisions are made.
A comprehensive 98-gene germline panel covers inherited predisposition across 23 cancer types, including BRCA1/2, Lynch syndrome genes, PALB2, ATM, CHEK2, and others.
A targeted panel for hereditary breast, ovarian, and other women's cancer risk indications — appropriate when the clinical suspicion is more specific.
Once a pathogenic variant is identified, single-site testing for biological relatives can be ordered to clarify individual risk before clinical decisions.
Clinical indications
Personal or family history of breast, ovarian, or colorectal cancer at young age
Multiple primary cancers in one individual or close relatives
Rare cancer types with known hereditary associations (e.g., male breast cancer)
Known pathogenic variant in the family — cascade testing for relatives
Treatment decisions where BRCA or other variant status is relevant (e.g., PARP inhibitor, olaparib)
Pre-surgical risk evaluation for contralateral mastectomy or risk-reducing surgery
Available tests
GC Genome
A 98-gene germline panel covering inherited cancer predisposition across 23 cancer types.
Specimen: EDTA whole blood
TAT: 17–21 days
GC Genome
Focused hereditary cancer panel for breast, ovarian, and other women's cancer risk indications.
Specimen: EDTA whole blood
Hereditary cancer
Suite 403, 133 Madina Munawara St, Amman, Jordan
+962 791 707 606 info@advancedconsensus.comMessage us on WhatsAppFor website inquiries, avoid patient names, national IDs, medical record numbers, or reports. Secure document exchange should happen through approved clinical channels.